Matthew Ramotar

Extended Results and Independent Validation of a Phase 2 Trial of Metastasis-Directed Therapy for Molecularly Defined Oligometastatic Prostate Cancer

Rachel Glicksman, Matthew Ramotar, Ur Metser et al. · International Journal of Radiation Oncology*Biology*Physics · 2022 · 23 citations

Medicine, Oncology, Urology +17

Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial

Jarey H. Wang, Alexander D. Sherry, Soha Bazyar et al. · Journal of Clinical Oncology · 2025 · 22 citations · Full text

Medicine, Oncology, Radiation Oncology +17

The influence of the “cancer” label on perceptions and management decisions for low-grade prostate cancer

Alejandro Berlín, Matthew Ramotar, Anna Santiago et al. · JNCI Journal of the National Cancer Institute · 2023 · 17 citations · Full text

Medicine, Oncology, Urology +17

Neurological Death is Common in Patients With EGFR Mutant Non-Small Cell Lung Cancer Diagnosed With Brain Metastases

Matthew Ramotar, Fábio Ynoe de Moraes, Archya Dasgupta et al. · Advances in Radiation Oncology · 2019 · 15 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Impact of EGFR mutation on outcomes following SRS for brain metastases in non-small cell lung cancer

Fábio Ynoe de Moraes, Alireza Mansouri, Archya Dasgupta et al. · Lung Cancer · 2021 · 12 citations

Medicine, Neurosurgery, Oncology +13